Table 2 Resource use description showing the proportion of individuals who were on medication and the number of laboratory tests performed during the study follow-up

Number at study end

795

288

537

44

245

316

48

 No medication

76 (9.6%)

31 (10.8%)

49 (9.1%)

1 (2.3%)

18 (7.3%)

14 (4.4%)

1 (2.1%)

 On medication

719 (90.4%)

Overall, 257 (89.2%)

Overall, 488 (90.9%)

Both drugs, 29 (65.9%)

Both drugs, 131 (53.5%)

Both drugs, 239 (75.6%)

All drugs, 26 (54.2%)

1 drug, 104 (36.1%)

1 drug, 115 (21.4%)

ART only, 10 (22.7%)

ART only, 87 (35.5%)

Diabetic only, 40 (12.7%)

ART only, 8 (16.7%)

2 drugs, 144 (50.0%)

2 drugs, 282 (52.5%)

Diabetic only, 4 (9.1%)

Hypertensive only, 9 (3.7%)

Hypertensive only, 23 (7.3%)

Diabetic only, 1 (2.1%)

3 drugs, 9 (3.1%)

3 drugs, 91 (17.0%)

Hypertensive only, 2 (4.2%)

ART and diabetic, 6 (12.5%)

ART and hypertensive, 3 (6.3%)

Hypertensive and diabetic, 1 (2.1%)

 Viral load test

597 (75.1)

0 (0.0)

0 (0.0)

34 (77.3)

160 (65.3)

0 (0.0)

31 (64.6)

 CD4 count test

87 (10.9)

0 (0.0)

0 (0.0)

2 (4.5)

23 (9.4)

0 (0.0)

3 (6.3)

 HbA1c test

7 (0.9)

171 (59.4)

4 (0.7)

22 (50.0)

2 (0.8)

130 (41.1)

22 (45.8)

 Fasting blood sugar test

33 (4.2)

273 (94.8)

45 (8.4)

34 (77.3)

10 (4.1)

300 (94.9)

42 (87.5)

 Random blood sugar test

48 (6.0)

104 (36.1)

42 (7.8)

13 (29.5)

12 (4.9)

130 (41.1)

16 (33.3)

 Haemoglobin test

41 (5.2)

7 (2.4)

5 (0.9)

2 (4.5)

12 (4.9)

2 (0.6)

3 (6.3)

 Cholesterol test

6 (0.8)

34 (11.8)

28 (5.2)

2 (4.5)

6 (2.4)

26 (8.2)

1 (2.1)

 Creatinine test

14 (1.8)

25 (8.7)

19 (3.5)

3 (6.8)

4 (1.6)

22 (7.0)

1 (2.1)

 Urine test

7 (0.9)

11 (3.8)

15 (2.8)

2 (4.5)

5 (2.0)

17 (5.4)

2 (4.2)

 Renal and liver function test

4 (0.5)

16 (5.6)

20 (3.7)

3 (6.7)

13 (6.1)

41 (13.0)

3 (6.3)

 Other tests^b

73 (9.2)

63 (21.9)

62 (11.5)

14 (31.1)

43 (20.2)

62 (19.7)

6 (12.5)